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Certain arachidonic acid (AA) metabolites have been de-
tected in psoriatic skin lesions. In this study the capacity 
of norrn.al epidermis and clinically uninvolved psoriatic ep-
idermis to transform AA into lipoxygenase products was 
determined in vitro. After incubating homogenized epi-
dermis with exogenous AA, the extracted lipids were iso-
lated by reverse-phase high-performance liquid chroma-
tography . Each chromatographic peak was characterized 
by its UV absorption spectrum and identified by its co-
elution with the appropriate authentic standard and by ra-
dioimmunoassay of its eluate fraction. Identified com-
pounds were quantitated by integrated UV absorbance. 
Leukotriene B4 (L TB4) was also identified by neutrophil 
chemokinesis. 
Normal epidermis generated 15-hydroxy-eicosa tetrae-
noic acid (15-HETE) and 12-HETE, the latter being more 
abundant. 5-Lipoxygenase products (LTB4' L TC4 , and 5-
Substantial evidence accumulated during the las t few years suggests that certain arachidonic acid (AA) products m ay be involved in the pathogenesis of psoriasis. High levels of 12-hydroxy-eicosatetraenoic acid (12-HETE) are present in keratomed psoriatic lesions [1] and in psoriatic 
scales [2]. and leukotriene B4(LBT 4)-like material can be recovered 
from abraded lesional skin [3] . The presence of these compounds 
may be of pathophysiologic relevance, because topical application 
ofLTB" to normal human skin [4] or intradermal infusion of12-
HETE [5] results in an indurated erythematous les ion character-
ized by neutrophil in filtra tion . Furthermore, LTB4 and 12-HETE 
stimulate DNA synthesis of cultured human keratinocytes [6,7] 
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HETE) were not detected. However, an unknown com-
pound exhibiting a triplet UV absorbtion spectrum with 
maximum at 274 mm was formed. Its formation was in-
hibited by 5,8,11, 14-eicosatetraynoic acid, but not by in-
domethacin or a specific 5-lipoxygenase inhibitor (REV 
5901). These data suggest that a di-HETE with a triene 
structure is one possible candidate for the unknow n com-
pound. Compared with normal epidermis, the formation 
of 12-HETE and the unknown di-HETE by uninvolved 
psoriatic epidermis was increased by 54% and 63%, re-
spectively. The formation of 12-HETE and the unknow n 
di-HETE in uninvolved psoriatic epidermis was stimulated 
to the same degree in the presence of the phospholipase 
inhibitor quinacrine. These results indicate that uninvolved 
psoriatic epidermis has an increased capacity to metabolize 
free AA into 12-lipoxygenase products. J In vest Dermatol 
87:47-52, 1986 
and of guinea pig epidermis in vivo [8]. A profound keratinocyte 
proliferation is also found after topical application of L TB4 to 
human skin [9]. These lip oxygenase products may, therefore, 
contribute to both the inflammation and the epidermal hyper-
proliferation present in psoriasis. 
There are indica tions that the metabolism of AA may be ab-
normal even in the uninvolved skin of psoriatics. Ziboh et al [10] 
reported that enzyme preparations from uninvolved psoriatic skin 
convert an increased proportion of [14C]AA into mono-HETEs 
and di-HETEs. In contras t, the release of12-HETE from abraded, 
uninvolved psoriatic skin has been found to be elevated only to 
an insignificant degree [11] . 
The presence of increased Iipoxygenase activi ty in the unin-
volved epidermis of psoriatics might be of relevance for under-
standing the pathophysiology of psoriasis. Therefore, the purpose 
of the present study was to characterize lip oxygenase activity of 
human epidermis in vitro, and to determine the capacity of un-
involved psoriatic epidermis to generate 12-HETE. 
MATERIALS AND METHODS 
Skin Specimens Informed consent was obtained from healthy 
adult volunteers without a history of skin disease and from pa-
tients with psoriasis vulgaris. Only donors using no medication 
within the previous 2 weeks were included . A strip of skin (ep-
idermis and some papillary dermis) were obtained from buttock 
skin with a keratome set at 0.2 mm. In psoriatic patients biopsies 
were taken at leas t 30 cm away from involved skin. The biopsy 
was immediately placed on ice and transported to the laboratories. 
Homogenates of Epidermis and Dermis After placing the 
biopsy in phosphate-buffered saline (PBS) at 55°C for 25 s the 
epidermis was peeled from dermis with a forceps and immediately 
placed in liquid nitrogen. The level of cleavage was examined in 
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hi stologic fro zen sections stained with hematoxylin and eosin. 
Epidermal specimens contaminated with dermis were discarded. 
Pieces of frozen epidermis were ground with a mortar and 
pestl e precooled with liquid nitrogen. The powdered tissue was 
suspended in 0. 6 ml Dulbecco's PBS (pH 7.4) with 2 mM glucose 
and 5 mM reduced gluthathione, and finally sonicated (50-W pulse, 
40 bursts/sample) at O°c. 
Reagents for Analysis of AA Metabolites Organic solvents 
and water of high-performan ce liquid chromatography (HPLC) 
grade were from Burdick & Jackson Laboratories, Inc., Muske-
gon , Michi gan. Just before use, all organic and aqueous solutions 
were filtered with 0.5 JL-MFH and 0.22 JL-MGS, respectively 
(Millipore). AA (Sigma) and [1 4C]AA and [3H]AA (New England 
Nuclea r) were purifi ed by silicic acid chromatography (5-mm 
glass column packed with 0.25 g Silicar CC-4, Mallinckrodt) . 
The column was eluted with ether: hexane (2: 98) followed by 
ether : hexane (10 :90), the latter containing AA. 
Synthetic 5-HETE, L TB4, LTC4 , L TD4, 6-trans-LTB4, 12-epi-
6-trans-L TB4 , 5S, 12S-L TB,J, 20-0H-L TB4, and 20-COOH-LTB4 
were gifts from Dr. Rokach, Merck-Frosst, Quebec, Canada. 12-
HETE was a gift fro m Dr. Sven Hammarstrom, Department of 
Physiological Chemistry, Karolinska Institutet, Stockholm, Swe-
den. The followin g inhibitors of eicosanoid metabolism were 
used: indo methacin (Sigma), a cyclooxygenase inhibitor; nordi-
hydroguaiareti c acid (NDGA) (Sigma) , a cyclooxygenase and Ji-
poxygenase inhibitor; 5,8 ,11 , 14-eicosatetraynoic acid (ETY A) (a 
gift from Dr. S. H ammarstrom, Stockholm, Sweden), a cycloox-
ygenase and Iipoxygenase inhibitor; and REV-5901 (Rev lon, 
Tuckahoe, N ew York) , an inhibitor of 5-lipoxygenase activity 
in human neutrophiJ s (Revl on, Tuckahoe, N ew York, unpub-
li shed results). 
Generation of AA Metabolites in Vitro Tissue samples were 
incubated with various concentrations of AA, unlabeled (Sigma) 
or 14C-Iabeled (55 mCi/ mmol , N ew England Nuclear), at 37°C. 
Incubations were stopped after various durations by adding 4 vol 
of ice-cold methanol containing 3H-Iabeled AA metabolites (10,000 
cpm , 40-120 C i/ mmol , N ew England Nuclear) as internal stan-
dards. The sample was left at 4°C for 15 min and then centrifuged 
at 1000 g for 10 n1.in to pellet denatured protein. The collected 
supernatant was diluted with acidified HzO (pH 3) to a methanol 
concentration of 25%. Formic acid was used for acidification . 
Lipids were extracted on ODS (octadecylsilyl) silica columns 
(Waters Associates, Milford , Massachusetts) as described by Lu-
derer et al [12] . After applying a vacuum, the column was ' pre-
washed with 2 ml methanol and 2 ml PBS (pH 3). Then the 
diluted, acidified sample was applied to the column and eluted 
sequentialJy with 2 ml w ater, 2 ml petroleum ether, and 2 ml 
methanol. The methanol fra ction containing AA derivatives was 
taken to dryness under N z and resuspended in 20 JLl methanol 
prior to HPLC. 
High-Performance Liquid Chromatography Ex tracted lip-
ids were separated by reversed-phase (RP) HPLC (Hewlett Pack-
ard HP 1090 equipped with a diode array detector) on a Hypersil 
O DS column (100 mm X 2.1 mm, 5-JLm particles) eluted with 
acetonitrile (AC N) in aqueous H3P04 (pH 3). The mobile phase 
was 20% AC N with linear increase to 30% over 2 min followed 
by linea r increases to 33% from 2-10 min, to 53% from 10-18 
min, to 57% from 18-23 min, and to 85% from 23-28 min . From 
28-33 min AC N was kept at 85 % . This elution procedure was 
modified from Van Rollin s et al [13] . The solvent flow was 0.8 
111.1 at 25°C, and the eluent was monitored by a diode array detector 
producing the UV absorbance as a function of wavelength for 
each chromatographi c peak. Data w ere analyzed using an inte-
grator that was programmed using injections of authentic stan-
dards to allow quantitation of the specific peaks . The elution times 
were standardized daily. 
The eluent was split between a fraction collector and a radio-
activity flow detector (Radiomatic, Flo-one model HS). The 3H 
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and 14C dpm were recorded separately, and the areas of the ra.., 
dioactivity peaks were also integrated . The recoveries of radio.., 
labeled standards added to the tissue samples were as follows: 
PGEz 90-96%, LTB4 79-87%, LTC4 66-72% , 5-HETE 70- 74% 
and 12-HETE 61-68%. ' 
Radioimmunoassays Eluate fractions cochromatographing with 
PGFza, PGEz, 15-HETE, and 12-HETE by RP-HPLC were evap_ 
orated under a stream of N z before dilution. 
A second antibody technique in which leukotriene-antibody 
complexes were precipitated by goat antirabbit immunoglobulin 
w as employed for the assay of LTB4 [14]. Samples were assayed 
at 3 dilutions in 0.02 M phosphate pH 7.2 with 0.14 M NaCI and 
1 % bovine serum albumin (BSA). The antibodies were gifts from, 
Merck, Sharp and Dohme (Nutley, N ew Jersey); LTB4 was pro.., 
vided by Merck-Frosst (Quebec, Canada) and [3H]L TB4 (30-60 
Ci/mmol) was from New England Nuclear (Boston, Massachu_ 
setts) . 
For 15- HETE and 12-HETE, a dextran-coated charcoal sepa.., 
ration RIA was used according to the manufacturers of the an.., 
tibodies (Seragen, Boston, Massachusetts). Samples were diluted 
in 0.1 M phosphate buffer containing 0.9% NaCI and 0.1 % BSA. 
The pH of the buffer was 7.2 for 15-HETE and 8.5 for 12-HETE. 
Each sample was assayed at 3 dilutions . [3H]15-HETE (30-60 
Ci/mmol) and [3H]12-HETE (40-80 Ci/mmol) were from New 
England Nuclea r. 
For PGFza an assay using a rabbit anti-PGF2a antibody (Upjohn, 
Kalamazoo, Michigan) and [3H]PGFza (150- 180 Ci/mmol, New 
England Nuclear) was performed as described by Fitzpatrick and 
Wynalda [15]. Dextran-coated charcoal was used to separate bound, 
from free ligand. A similar method using a rabbit anti-PGE~ 
antibody (Upjohn) and [3H]PGEz (100- 200 Ci/ mmol, New Eng, 
land Nuclear) was used for PGEz [16]. 
Protein Analysis Protein was detected by the fluorescamine 
method described by Udenfriend et al [17] . As described above 
protein was initially denatured with methanol and pelleted b; 
centrifugation. The pellet was washed twice in 3% perchlori~ 
acid, resuspended in 6 N HCI, and incubated at 100°C for 18 h. 
The hydrolyzed protein buffered with 6 N NaOH and 0.2 I'v\ 
sodium borate to pH 9 was then mixed with fluorescamine, freshly 
dissolved in acetone (final concentration 0.025 mg/ml). The re-
sulting fluorescence was read immediately on a fluorimeter. A 
standard curve was obtained using dilutions of a 0.1 mM glycine 
standard. 
Neutrophil Chemokinesis Chemokinesis was measured using 
an agarose microdrop technique [18] . Normal human neutrophiJs 
isolated from EDT A- blood [19] were suspended in 0.2 mJ min, 
imal essential medium (MEM) containing 10% heat-inactivated 
human serum and 60 mM HEPES at pH 7.3. An equal volume 
of 0.4% agarose in a similar medium was added, and neutrophil 
and agarose were thoroughly mixed. Two microliters of this 
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Figure 1. RP-HPLC of authentic AA metabolites . Column: Hypers~ 
ODS (100 X 2.1 mm) ; flow rate: 0.8 mIl min. The UV detector was se~ 
at 270 nm from 0- 7 min, at 190 nm from 7-10 min, at 270 nm frOll\ 
10-19 min and at 235 nm from 19 min. Retention times of authentic 
eicosanoids are indicated by arrows. 
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Figure 2_ RP-HPLC of lipids extracted from homogenized human ep-
idermis incubated with 25 f.LM AA and 0.3 f.LCi [1"ClAA (55 mCi/mmol) 
for 30 min at 37°C. The UV absorbance (a) was monitored at 270 nm 
from 0-19 min and at 235 nm from 19 min. b, The radioactivity . Retention 
times of authentic eicosanoids are indicated by arrows. 
mixture were placed on the bottom of each well of a microtiter 
plate. The plate was precooled on ice to allow the gel to solidify 
and stick. Then, 0.1 mI MEM containing 10% heat-inactivated 
human serum and 60 mM HEPES at pH 7.3, with or without 
chemokinetic agents, were added to each well. After incubation 
for 2 h at 3rC in a humidified atmosphere, the radius of the 
agarose droplet was measured using a concentric ruler in an in-
verted microscope. N eutrophil movement was expressed as the 
chemokinetic index (Cl) as follows: 
radius in test well CI 
radius in control well 
Statistical Analysis Experiments were done in duplicates. Re-
sults were expressed as means ± SD. Statistical significance was 
assessed by Wilcoxon's rank-sum test for paired and unpaired 
samples. A p value below 0.05 was considered significant. 
RESULTS 
Separation and Identification of AA Metabolites Generated 
by Normal Human Epidermis To determine the ability of 
the RP-HPLC procedure to separate metabolites of AA, a mixture 
of authentic standards was analyzed, As shown in Fig 1 the method 
permitted the separation of the AA metabolites that are currently 
of major interest, and this separation was obtained within 30 min. 
Table L Formation of a Leukotriene(L T)-like Compound in 
the Presence of Cyclooxygenase and Lipoxygenase Inhibitors 
Concentration 
Inhibitor (M) 
Control 
Indomethacin 10 - 6 
10 - 5 
5,8, ll,l4-Eicosatetraynoic acid (ETYA) 10 - 6 
10 - 5 
10- 4 
REV-5901 10- 5 
10 - 4 
Results arc expressed as mean ± SO of 5 experiments. 
LT-like 
(%) 
, 100 
105 ± 8 
94 ± 10 
62 ± 12 
16 ± 4 
7 ± 3 
104 ± 9 
101 ± 9 
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Figure 3. UV spectrometry of peaks I-V shown in Fig 2. 
300nm 
To detect prostaglandins (PGs) by RP-HPLC the UV detector 
was set at 190 nm. In biologic samples, other polar lipids than 
PGs absorb substantial UV radiation below 200 nm. It is, there-
fore, an advantage to analyze PGs by RIA rather than by UV 
absorbtion . For that purpose PGs separated by RP-HPLC were 
collected and then analyzed by RIA. All other compounds were 
identified and quantitated by both integrated optical density and 
RIA . 
Homogenized epidermis was incubated with AA , both unla-
beled and labeled with 14C, and the lipids extracted from the 
reaction mixture were subj ected to RP-HPLC (Fig 2) . Several 
compounds were detected by monitoring UV absorbance and 14C 
radioactivity. The peak with a retention time of 16.9 min (com-
pound I) was radioactive (Fig 2) and disappeared in the presence 
of ETY A, but not of indomethacin or REV 5901 (Table I). These 
data suggest that compound I is the product of a lipoxygenase, 
although not of 5-lipoxygenase. It exhibited a triplet absorption 
spectrum with maximum at 274 nm (Fig 3), indicating the pres-
ence of a conjugated triene structure similar to that ofLTs. How-
ever, its retention time and UV absorbtion spectrum were dif-
ferent from those of the known LT (L TB4, LTC4, LTD,,) and 
their known isomers . Eluate fractions of peak I contained weak 
chemokinetic activity (Fig 4). The identity of this L T -like com-
pound is presently being determined by gas chromatography-
mass spectrometry (GC-MS). 
The peaks eluting at 20.0 min (compound II) and at 20.2 min 
(compound III) (Fig 1) showed maximum UV absorption at 235 
nm (Fig 3) . No radioactivity was associated with compounds II 
and III (Fig 2). They are, therefore, not metabolites of AA. How-
2.0 
1.8 
x 
w 
0 
~ 1.6 
'-' ~ 
w 1.4 z ;;;: 
0 
:E 
w 1.2 :r 
'-' 
1.0 
0 
CONTROL ' I '----' 
AUTHENTIC LT!4 ELUATE 
AT 16.9 MIN AT 16.4 MIN 
Figure 4. Neutrophil chemokinetic activity of eluate fractions of the 
unknown, di-HETE-Iike compound (16.9 min) and of the area coeluting 
with authentic LTB. (16.4 min). Controls contained buffer alone. Data 
are expressed as the mean chemokinetic index (colli mils) and SD (bars) for 
5 experiments. Experiments were done in qua triplica te. The statistical 
significance of responses is indica ted by a * (p < 0.0001) and by a + 
(p < 0.01). 
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Table II. Analysis by Radioimmunoassay (RIA) of 
Compounds IV and V Purified by Reverse-Phase 
High-Pressure Liquid C hromatography 
Compound 
IV 
V 
15-HETE 
(ng/ ml) 
32.4 ± 2.9 
2.1 ± 0.2 
12-HETE 
(ng/ml) 
1.8 ± 0.2 
28.2 ± 3.1 
C ompounds IV and V (30 ng/ ml) as measured by integ rated oprical intensity 
were analyzed by RIA . Values arc means ± SO 0[8 experiments. HETE = hydroxy-
eicosatctranoic acid. 
ever, their disappearance in the presence of ETY A 10- 5 M, but 
not of indomethacin 10 - 6 M (data not shown) , suggests that they 
may be lipoxygenase products of a fatty acid different from AA. 
A minor peak was produced at 20.6 min (compound IV) and 
a major peak at 21.4min (compound V) (Fig 2). These compounds 
were radioactive and cochromatographed with authentic ls-HETE 
and 12-HETE, respectively. For further characterization of com-
pounds IV and V, eluate fractions were analyzed by RIA (Table 
II). Taking in to account that there was approximately 5% cross-
reactivity between 1s-HETE and 12-HETE in the RIA assays for 
ls-HETE and 12-;HETE, the data shown in Table I strongly 
suggest, that compound IV is ls-HETE, and that compound V 
is 12-HETE. However, GC-MS analysis is required for a defin-
itive verification. 
RP-HPLC produced a significant radioactive peak at 18.4 min, 
but no UV absorbance was observed in that area (Fig 2). This 
compound was not a spontaneous degradation prod uct of AA, 
because it was not present when boiled epidermis was incubated 
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w ith AA (data not shown), and because it disappeared w hen 
epidermis was incubated with AA in the presence of ETY A (data 
not shown). The identity of this compound remains undeter-
mined. 
s-Lipoxygenase products (s-HETE, L TB4, isomers of L TB4 , 
w-oxidation products of L TB4 , LTC4) were not detected in epi-
dermal samples (30-80 mg wet weight), by RP-HPLC (UV ab-
sorbance and 14C radioactivity) (Fig 2) or by RIA. Furthermore, 
eluate fractions of the area cochromatogra phing with authentic 
LTB4 did not show any chemokinetic activity (Fig 4) . 
The radioactivity chromatogram showed peaks coeluting with 
authentic PGFza and PGEz (Fig 2). The identity of these 2 peaks 
coeluting with PGF2a and PGEz was confirmed by RIA (data not 
shown). 
General Properties of the 12-Lipoxygenase Activity ofHu-
man Epidermis The formation of 12-HETE was negligible 
w hen AA was incubated in the presence of boiled epidermis (data 
not shown). Both NDGA (ID5o = 3 X 10- 5 M) and ETYA (lDso 
= 2 X 10- 7 M) inhibited 12-HETE formation, the latter being 
more potent (Fig Sa). Indomethacin, a cyclooxygenase inhibitor, 
did not affect 12-HETE formation at a conventional concentration 
(10 - 6 M) , but at higher concentrations some inhibition was ob-
served (Fig Sa). 
The in vitro synthesis of 12-HETE was dependent on time and 
the amou nt of tissue added. Fig 5 b shows that more than 90% 
of the 12-HETE was generated within 30 min . There was a linear 
relationship between the rate of12-HETE generated and the am ount 
of protein (Fig sc). This allowed expression of the results in re-
lation to the protein concentration. 
The rate of 12-HETE formation increased with increasing con-
centrations of exogenous AA in the range from 10 - 6-10 - 4 M (Fig 
.. 
10 15 
PROTEIN (mo) 
20 
Figure 5. n, Epidermal 12-HETE forma-
tion in the presence of ETY A, NOGA, and 
indomethacin. Incubations were carried OUt 
for 30 min at 37°C. Each poillt and bar rep-
resents the mean and SO for 6 experiments. 
b, Time-course of 12-HETE formation by 
human epidermis in the presence of 25 /-LM 
AA. Each poi"It and bar arc the mean and 
SO of 6 experiments. c, 12-HETE forma-
tion by epidermis as plotted as a function 
of epidermal protein. r = 0.90, P < 0.01. 
d, Epidermal 12-HETE formation as a func-
tion of the concentration of AA. Incubations 
were carried out for 30 min. Each poillt and 
bar represent the mean and SO for 8 exper-
IInents . 
o 
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Table III. Formation of 12-HETE by Epidermis Separated 
from Dermis by Hea t or Pronase 
Pretreatment 
Heat (55°C for 20 s) 
Pronase (37°C for 20 min) 
12-HETE 
(nm ollg protein/30 min) 
99 ± 12 
105 ± 14 
Results arc expressed as means ± SD of 5 experiments. Epidermis was incubated 
wi th 25 JLM arachidonic acid at 37"C for 30 min . 
Sci) . At higher AA concen trations an inhibition of 12-HETE for-
mation occurred . Addition of the calcium ionophore (0.2-5 f.LM) 
did not alter 12-HETE form ation (data not shown) . 
These results were obtained with epidermis separated from 
dermis by exposure to 55°C for 25 s. Similar 12-HETE formation 
was found when pronase was used to separate epidermis and 
dermis (Table III). In addition , when 12-HETE formation was 
determined in unsepara ted skin samples, containing both epider-
mis and dermis, exposure to heat (55°C for 25 s) did not alter the 
total 12-HETE formation (data not shown) . 
12-HETE Formation in Uninvolved Psoriatic Epider-
mis Qualitative analysis showed that uninvolved psoriatic ep-
idermis generated compounds similar to those of n01"mal epider-
mis. When the data were qu antitated by integrated optical density 
at 238 nm, it was discovered that the 12-HETE formation was 
increased in uninvolved pso riati c epidermis although there was 
some overlap with normal epidermis. The data shown in Fig 6 
were obtained by incuba ting epidermis with 25 f.LM AA for 30 
min, but a similar difference was present at other AA concentra-
tions (0 and 100 f.LM) and at other incubation times (10 and 45 
min) (data not shown) . Increased amounts of the LT-like com-
pound were also produced by uninvolved psoriatic epidermis 
(Table IV). The formation of this compound was expressed rel-
ative to the formation in normal epidermis, because the molecular 
weight was not known . On the other hand , the formation of 15-
HETE in normal and uninvolved psoriatic epidermis was sim.ilar. 
To determine whether increased formation of 12-HETE in un-
involved psoriatic epidermis was secondary to raised phospho-
lipase A2 activity, experiments were performed in the presence 
of quinacrine, a phospholi pase inhibitor. When epidermis, normal 
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Figure 6. 12-HETE formation by epidermis from normal and unin-
volved psoriatic skin . Incubations were carried out for 30 min in the 
presence of 25 J1.M AA. The means are indicated by hor;zolltai bars. Un-
involved psoriasis vs normal: p < 0.0001. 
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Table IV. Formation of a di-HETE-like Compound by 
Homogenized Epidermis of N ormal Skin and Uninvolved 
Psoriatic Skin 
Epidermis 
di-HETE-like Compound 
% 
Normal 100 
Uninvolved psoriasis 163 ± 33" 
Results are expressed as mea n :!: SO of 8 ex periments. 
"p < 0.00 1. 
or uninvolved psoriatic, was incubated with quinacrine, but in 
the absence of exogenous AA , negligible amounts of 12-HETE 
were produced (Table V), indica ting that quinacrine did inhibit 
the release of free AA. After adding exogenous AA (Table V) 
12-HETE was produced in amounts similar to those seen in the 
absence of quinacrine (Fig 6). Furthermore, even in the presence 
of quinacrine, uninvolved psoriatic epidermis generated more 12-
HETE than normal epidermis. 
DISC USSION 
In the present study we have analyzed the AA metabolism of 
homogenized human epidermis by RP-HPLC and RIA. Our RP-
HPLC system allowed the separa tion of most AA metabolites of 
AA within 30 min. Homogenized human epidermis generated 
predominantly 12-HETE. The formation of 12-HETE was in-
creased by about 50% in unin volved psoriatic epidermis. This 
increase of 12-HETE formation was observed under circum-
stances where phospholipase activity was inhibited, suggesting 
that the 12-lipoxygenase activity was raised in the epidermis of 
clinically uninvolved psoriatic skin . Although the use of broken 
cell preparations may not completely mimic the in vivo situation , 
our results do indicate that abnormal metabolism of AA is not 
confined to the les ional skin of pso riatics. 
The finding of 12-HETE as the main lipoxygenase product of 
human epidermis is in agreement with in vitro experiments done 
with homogenized human skin [20) and suspended epiderm al cells 
[21 J. We were unable to detect L TB4, even with a chemokinetic 
assay that is sensitive to concentrations as low as 10- 13 M. In 
contrast, small amounts of L TB4 are generated by suspended 
epidermal cells [21,22). This difference in 5-lipoxygenase activity 
may be explained by the fact that the 5-lipoxygenase enzyme, 
unlike the 12-lipoxygenase enzyme, req uires an acti va tion step. 
This activation may not take place in broken cell preparations, 
even in the presence of the calcium ionophore A23187. 
The increased 12-HETE formation in homogenized epidermis 
from uninvolved psoriatic skin is consistent with results obtained 
with enzy mes prepa red from a mixtu re of epidermis and dermis 
[10). In that study HETEs were analyzed by thin-la yer cllro-
matography not allowing 12-HETE to be separated from other 
HETEs. In another study 12-HETE has been measured in fluid 
collected fro m abraded human sk in [11 J. Based on the tudy of 
5 samples of unin volved psoriatic skin , onl y an insignificant in-
crease of 12-HETE release was found [11] . This difference in 
Table V. 12-HETE Formation by N ormal and Uninvolved 
Psoriatic Epidermis Incubated With and Without Arachidonic 
Acid in the Presence of 10- 4 M Quinacrine 
Tissue 
Normal 
Uninvolved psorias is 
Arachidonic Acid 
(J1.M) 
o 
25 
o 
25 
12-HETE 
(nmol/g protein/3D min) 
< 1 
92 ± 13 
< 1 
142 ± 20' 
Results arc expressed as means ± SO of 5 experiments. 
"p < 0.001. 
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results may reRect differences in sample coll ection . T hus, plate-
lets, ri ch sources of1 2-HETE, most likely leak into abraded areas 
and thereby contribute to the 12-HETE measured in the abraded 
skin. A potential di ffe rence between pso ri ati c and no rm al epi-
dermis may therefore be obscured. 
T he concept that the transformation of AA is abnormal in 
uninvolved psori atic epidermis is supported by two independent 
studies showing increased phospholipase A2 ac ti vity in the un-
invo lved epidermis of pso riasis [23 ,24]. The in creased epiderm al 
12-HETE formati on found by us might , therefo re, be secondary 
to an enhanced release of free AA. However, the in ability of a 
phospholipase A2 inhibitor to norm alize the synthesis of 12-HETE 
by unin vo lved psoriatic epidermis seems to sugges t that the ac-
tivity o f 12-lipoxygenase per se is in creased in uninvolved pso-
ri ati c epidermis. Furthermore, our use of exogenous AA may 
have exaggerated a difference between normal and psoriatic ti ssue. 
T he presence of extremely high levels o f 12-HET E in psori atic 
skin lesions is well es tablished [1,2], but the cellular source of 
lesional 12-HETE has not been defined. In the study of H am-
marstrom et al [1] an average of 4. 1 t-Lg 12-HET E was contained 
per g wet weight o f tissue. From our data it can be calculated 
that app roximately 6.4 t-Lg 12-HETE ca n be generated per g wet 
weight in 30 min . Although our results were obtained in the 
presence of high leyels of exogenous AA, these resul ts indicate 
that human epidermis has the ca pacity to produ ce the 12-HETE 
present in pso riatic lesions. 
From a pathophysiologic poin t of view th e enhanced 12-
lipoxygenase activity in unin volved psoriati c epidermis may be 
of great importance. Although less potent than L TB4 , 12-HETE 
induces the migra ti on of neutrophils both in vitro [25] and in 
vivo [5]. In addition, DNA synthes is of both cultured human 
kera tinocytes [6] and guinea pig epidermis in vivo [7.1 is stimulated 
by 12-HETE. Stimuli leadin g to increased 12-HETE synthesis 
may, th erefore, be key events in the evolution of uninvolved 
psori atic epidermis into clinicaLly involved epidermis. 
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